Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

v3.23.3
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Service Line
Revenue by Service Line
Three Months Ended September 30,
(in thousands) 2023 2022
Biologics and drug delivery
Disposable products $ 455  $ 798 
Services and license fees 3,032  1,448 
Subtotal – Biologics and drug delivery revenue 3,487  2,246 
Functional neurosurgery navigation and therapy
Disposable products 1,874  2,045 
Services 44  375 
Subtotal – Functional neurosurgery navigation and therapy
1,918  2,420 
Capital equipment and software
Systems and software products 81  287 
Services 276  193 
Subtotal – Capital equipment and software revenue 357  480 
Total revenue $ 5,762  $ 5,146 
Nine Months Ended September 30,
(in thousands) 2023 2022
Biologics and drug delivery
Disposable products $ 1,395  $ 2,873 
Services and license fees 8,136  3,935 
Subtotal – Biologics and drug delivery revenue 9,531  6,808 
Functional neurosurgery navigation and therapy
Disposable products 5,550  5,706 
Services 930  1,125 
Subtotal – Functional neurosurgery navigation and therapy
6,480  6,831 
Capital equipment and software
Systems and software products 432  1,171 
Services 702  567 
Subtotal – Capital equipment and software revenue 1,134  1,738 
Total revenue $ 17,145  $ 15,377